233 related articles for article (PubMed ID: 25329115)
21. [The metabolic syndrome and antipsychotics in children and adolescents].
Dori N; Green T
Harefuah; 2011 Oct; 150(10):791-6, 814, 813. PubMed ID: 22111125
[TBL] [Abstract][Full Text] [Related]
22. The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).
Kurylev AA; Brodyansky VM; Andreev BV; Kibitov AO; Limankin OV; Mosolov SN
Psychiatr Danub; 2018 Jun; 30(2):157-163. PubMed ID: 29930225
[TBL] [Abstract][Full Text] [Related]
23. Serum concentrations of risperidone and aripiprazole in subgroups encoding CYP2D6 intermediate metabolizer phenotype.
Hendset M; Molden E; Knape M; Hermann M
Ther Drug Monit; 2014 Feb; 36(1):80-5. PubMed ID: 24232129
[TBL] [Abstract][Full Text] [Related]
24. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.
Brandl EJ; Frydrychowicz C; Tiwari AK; Lett TA; Kitzrow W; Büttner S; Ehrlich S; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ; Puls I
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):134-41. PubMed ID: 22426215
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
27. Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials.
Edwards SJ; Smith CJ
Clin Ther; 2009 Jun; 31 Pt 1():1345-59. PubMed ID: 19698898
[TBL] [Abstract][Full Text] [Related]
28. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
Maayan L; Correll CU
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
[TBL] [Abstract][Full Text] [Related]
29. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
[TBL] [Abstract][Full Text] [Related]
30. Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain.
Schwarz E; Steiner J; Guest PC; Bogerts B; Bahn S
World J Biol Psychiatry; 2015 Jan; 16(1):22-30. PubMed ID: 24001020
[TBL] [Abstract][Full Text] [Related]
31. Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure.
Kiss Á; Menus Á; Tóth K; Déri M; Sirok D; Gabri E; Belic A; Csukly G; Bitter I; Monostory K
Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):71-82. PubMed ID: 30604050
[TBL] [Abstract][Full Text] [Related]
32. Metabolic effects of antipsychotics in prepubertal children: a retrospective chart review.
Ebert T; Midbari Y; Shmilovitz R; Kosov I; Kotler M; Weizman A; Ram A
J Child Adolesc Psychopharmacol; 2014 May; 24(4):218-22. PubMed ID: 24816004
[TBL] [Abstract][Full Text] [Related]
33. Use of antipsychotics in children and adolescents.
Findling RL; Steiner H; Weller EB
J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
[TBL] [Abstract][Full Text] [Related]
34. ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics.
Liu YR; Loh EW; Lan TH; Chen SF; Yu YH; Chang YH; Huang CJ; Hu TM; Lin KM; Yao YT; Chiu HJ
Pharmacogenomics J; 2010 Feb; 10(1):30-9. PubMed ID: 19918262
[TBL] [Abstract][Full Text] [Related]
35. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
36. CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studies.
Rodríguez-Antona C; Gurwitz D; de Leon J; Llerena A; Kirchheiner J; de Mesa EG; Ibarreta D
Pharmacogenomics; 2009 Apr; 10(4):685-99. PubMed ID: 19374522
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment.
van de Bilt MT; Prado CM; Ojopi EP; Sousa RT; Loch AA; Zanetti MV; Talib LL; Gattaz WF
Schizophr Res; 2015 Oct; 168(1-2):587-8. PubMed ID: 26298540
[TBL] [Abstract][Full Text] [Related]
38. Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study.
Gebhardt S; Theisen FM; Haberhausen M; Heinzel-Gutenbrunner M; Wehmeier PM; Krieg JC; Kühnau W; Schmidtke J; Remschmidt H; Hebebrand J
J Clin Pharm Ther; 2010 Apr; 35(2):207-11. PubMed ID: 20456740
[TBL] [Abstract][Full Text] [Related]
39. Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
Tiwari AK; Zai CC; Meltzer HY; Lieberman JA; Müller DJ; Kennedy JL
Hum Psychopharmacol; 2010 Apr; 25(3):253-9. PubMed ID: 20373477
[TBL] [Abstract][Full Text] [Related]
40. Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.
Martínez-Ortega JM; Funes-Godoy S; Díaz-Atienza F; Gutiérrez-Rojas L; Pérez-Costillas L; Gurpegui M
Eur Child Adolesc Psychiatry; 2013 Aug; 22(8):457-79. PubMed ID: 23503976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
